STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Research and development	$ 16,440	$ 19,436
Sales and marketing	6,979	2,336
General and administrative	14,843	8,788
Total operating expenses	38,262	30,560
Loss from operations	(38,262)	(30,560)
Interest expense, net	(1,491)	(185)
Gain on Loan Forgiveness		647
Change in fair value of SAFEs		(10,390)
Loss before provision for (benefit from) income taxes	(39,753)	(40,488)
Provision for (benefit from) income taxes	7	(153)
Net loss	$ (39,760)	$ (40,335)
Net loss per share, basic	$ (1.69)	$ (3.11)
Net loss per share, diluted	$ (1.69)	$ (3.11)
Weighted-average number of shares outstanding, basic	23,557,846	12,982,472
Weighted-average number of shares outstanding, diluted	23,557,846	12,982,472